SEC Form 4 · accession 0000914190-26-000120
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Geist
Officer — PRESIDENT, PROTEIN SCIENCES
Period of report
Aug 15, 2026
Accepted (ET)
Aug 18, 2026 · 5:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2026 | M | 6,416 | $0.00 | A | 26,919 | D | |
| Common Stock | Aug 15, 2026 | F | 1,976 | $72.40 | D | 24,943 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Restricted Stock UnitsF1,F3 | — | Aug 15, 2026 | M | 567 | D | — | — | Common Stock | 567 | 8,507 | D |
| Performance Restricted Stock UnitsF1,F3 | — | Aug 15, 2026 | D | 8,507 | D | — | — | Common Stock | 8,507 | 0 | D |
| Performance Stock Options (Right to Buy)F5 | $84.61 | Aug 15, 2026 | D | 22,898 | D | — | — | Common Stock | 22,898 | 1,526 | D |
| Restricted Stock UnitsF1,F7 | — | Aug 15, 2026 | M | 2,623 | D | — | — | Common Stock | 2,623 | 2,623 | D |
| Restricted Stock UnitsF1,F10 | — | Aug 15, 2026 | M | 3,226 | D | — | — | Common Stock | 3,226 | 6,452 | D |
| Stock Options (Right to Buy)F2 | $100.39 | holding | — | — | — | — | Feb 1, 2029 | Common Stock | 15,912 | 15,912 | D |
| Stock Options (Right to Buy)F2 | $94.52 | holding | — | — | — | — | Aug 15, 2029 | Common Stock | 29,600 | 29,600 | D |
| Stock Options (Right to Buy)F4 | $84.61 | holding | — | — | — | — | Aug 15, 2030 | Common Stock | 30,059 | 30,059 | D |
| Performance Restricted Stock UnitsF1,F6 | — | holding | — | — | — | — | — | Common Stock | 15,738 | 15,738 | D |
| Stock Options (Right to Buy)F8 | $74.91 | holding | — | — | — | — | Aug 15, 2034 | Common Stock | 21,204 | 21,204 | D |
| Performance Restricted Stock UnitsF1,F9 | — | holding | — | — | — | — | — | Common Stock | 19,355 | 19,355 | D |
| Stock Options (Right to Buy)F11 | $53.60 | holding | — | — | — | — | Aug 15, 2035 | Common Stock | 24,758 | 24,758 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F103,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
- F11Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.
- F2100% vested.
- F3On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited.
- F4Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
- F5On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited.
- F6Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F72,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
- F8Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- F9Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).